APA (7th ed.) Citation

Jin, R., Haughton, J. M., Goddard, E. J., Courmier, D., Radziszewski, W., Meadows, R. H., . . . Cohen, S. Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Jin, Ran, James M. Haughton, Emily J. Goddard, Delphine Courmier, Waldemar Radziszewski, Rachael H. Meadows, James Piercy, and Stanley Cohen. Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme. Adis, Springer Healthcare.

MLA (9th ed.) Citation

Jin, Ran, et al. Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme. Adis, Springer Healthcare.